MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-02
DOI
10.1002/cam4.3907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Application of Computational Methods in Precision Oncology
- (2020) Orestis A. Panagiotou et al. JAMA Oncology
- Review of precision cancer medicine: Evolution of the treatment paradigm
- (2020) Apostolia M. Tsimberidou et al. CANCER TREATMENT REVIEWS
- Inferring tumor progression in large datasets
- (2020) Mohammadreza Mohaghegh Neyshabouri et al. PLoS Computational Biology
- Current trend and development in bioinformatics research
- (2020) Yuanyuan Fu et al. BMC BIOINFORMATICS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- TISIDB: an integrated repository portal for tumor-immune system interactions
- (2019) Beibei Ru et al. BIOINFORMATICS
- Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
- (2019) Hendrik Ungefroren EXPERT OPINION ON THERAPEUTIC TARGETS
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- B7-H4, a promising target for immunotherapy
- (2019) Jia-Yu Wang et al. CELLULAR IMMUNOLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Targeting the IDO1 pathway in cancer: from bench to bedside
- (2018) Ming Liu et al. Journal of Hematology & Oncology
- Mitochondrial ribosomes in cancer
- (2017) Hyun-Jung Kim et al. SEMINARS IN CANCER BIOLOGY
- Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
- (2017) Federica Sotgia et al. Oncotarget
- Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy
- (2017) Federica Sotgia et al. Oncotarget
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- (2016) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells
- (2016) Liancheng Zhu et al. ONCOLOGY REPORTS
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
- (2015) Liancheng Zhu et al. Oncotarget
- Identification of Thyroid Carcinoma Related Genes with mRMR and Shortest Path Approaches
- (2014) Yaping Xu et al. PLoS One
- Integrated analysis of germline and somatic variants in ovarian cancer
- (2014) Krishna L. Kanchi et al. Nature Communications
- POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
- (2013) Beth Y. Karlan et al. GYNECOLOGIC ONCOLOGY
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
- (2011) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior
- (2011) Yue Wang et al. Journal of Zhejiang University-SCIENCE B
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells
- (2011) Sevtap Savas et al. PLoS One
- Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas
- (2009) K.-T. Kuo et al. CANCER RESEARCH
- Association of LETM1 and MRPL36 Contributes to the Regulation of Mitochondrial ATP Production and Necrotic Cell Death
- (2009) L. Piao et al. CANCER RESEARCH
- HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation
- (2009) M. L. del Rio et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer
- (2009) Anne P. G Crijns et al. PLOS MEDICINE
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now